These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 2899890
21. Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene. Yarden Y, Weinberg RA. Proc Natl Acad Sci U S A; 1989 May; 86(9):3179-83. PubMed ID: 2470093 [Abstract] [Full Text] [Related]
22. Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product. Mikami Y, Davis JG, Dobashi K, Dougall WC, Myers JN, Brown VI, Greene MI. Proc Natl Acad Sci U S A; 1992 Aug 15; 89(16):7335-9. PubMed ID: 1354355 [Abstract] [Full Text] [Related]
25. Ligand-independent tyrosine phosphorylation of the receptor encoded by the c-neu oncogene. Boccaccio C, Gaudino G, Cilli M, Mondino A, Comoglio PM. Growth Factors; 1991 Aug 15; 5(3):233-42. PubMed ID: 1685656 [Abstract] [Full Text] [Related]
26. Alterations of the c-erbB2 gene in human breast cancer. Zoll B, Kynast B, Corell B, Marx D, Fischer G, Schauer A. J Cancer Res Clin Oncol; 1992 Aug 15; 118(6):468-73. PubMed ID: 1352298 [Abstract] [Full Text] [Related]
32. A subdomain in the transmembrane domain is necessary for p185neu* activation. Cao H, Bangalore L, Bormann BJ, Stern DF. EMBO J; 1992 Mar 15; 11(3):923-32. PubMed ID: 1347745 [Abstract] [Full Text] [Related]
33. Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein. Weiner DB, Kokai Y, Wada T, Cohen JA, Williams WV, Greene MI. Oncogene; 1989 Oct 15; 4(10):1175-83. PubMed ID: 2571965 [Abstract] [Full Text] [Related]
34. Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-dependent signaling and oncogenic transformation. Qian X, Dougall WC, Fei Z, Greene MI. Oncogene; 1995 Jan 05; 10(1):211-9. PubMed ID: 7824275 [Abstract] [Full Text] [Related]
36. Modulation of a Mr 175,000 c-neu receptor isoform in G8/DHFR cells by serum starvation. Epstein RJ, Druker BJ, Roberts TM, Stiles CD. J Biol Chem; 1990 Jun 25; 265(18):10746-51. PubMed ID: 1972380 [Abstract] [Full Text] [Related]
37. Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein. Brandt-Rauf PW, Pincus MR, Chen JM. J Protein Chem; 1989 Dec 25; 8(6):749-56. PubMed ID: 2576207 [Abstract] [Full Text] [Related]
38. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase. Rogers JA, Cheng HY, Smithgall TE. Cell Growth Differ; 2000 Nov 25; 11(11):581-92. PubMed ID: 11095247 [Abstract] [Full Text] [Related]
39. GM3 content modulates the EGF-activated p185c-neu levels, but not those of the constitutively activated oncoprotein p185neu. Sottocornola E, Berra B, Colombo I. Biochim Biophys Acta; 2003 Dec 30; 1635(2-3):55-66. PubMed ID: 14729068 [Abstract] [Full Text] [Related]
40. Cloning and activation of the Syrian hamster neu proto-oncogene. Nakamura T, Ushijima T, Ishizaka Y, Nagao M, Arai M, Yamazaki Y, Ishikawa T. Gene; 1994 Mar 25; 140(2):251-5. PubMed ID: 7908275 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]